Aravis and Wellington Partners have co-led a CHF 16m investment in Swiss biotechnology company Evolva in a second tranche of the company's Series-B financing, taking the total amount raised to EUR 44m.
Glass Container companies are portfolio companies of Horizon Capital’s Western NIS Enterprise Fund
Seed investor Heartbeat Labs will retain a 10% stake in Fernarzt
Innovery is a portfolio company of Wisequity IV, which closed on €215m and is currently 92% deployed
Fund will be larger than its predecessor, which closed on €280m in July 2018